Key result
Open-heart surgery for severe RHD linked to ~26% higher absolute survival vs medical controls.
Why the study?
Literature is sparse regarding outcomes after valvular surgery in patients with severe chronic rheumatic heart disease in low- and middle-income countries.
Does open-heart surgery improve survival in patients with severe chronic rheumatic heart disease in a low-income country compared to medical therapy?
Observational (n=101)
Yes
Does open-heart surgery improve survival in patients with severe chronic rheumatic heart disease in a low-income country compared to medical therapy?
Effect estimate: RR 1.51 (95% CI 1.15-1.97)
Absolute Event Rate: 83% vs 57%
p-value: p=0.004
Cardiac surgery for severe chronic rheumatic heart disease is feasible in low-income countries and significantly improves mid-term survival compared to medical therapy.
Supports surgical intervention for severe RHD in low-income countries; extends evidence to high-burden, resource-limited settings.
Objectives The literature is sparse regarding outcomes after valvular surgery in patients with severe chronic rheumatic heart disease (RHD) in low- and middle-income countries (LMICs). We aimed to evaluate mid-term outcomes in patients with severe chronic RHD who underwent open-heart surgery in Ethiopia, and evaluate the durability of the operated valves during follow-up. Methods This study implemented an observational design, with 104 patients screened for cardiac surgery, of whom 52 were excluded. Outcome measures and clinical and echocardiographic data after cardiac surgery were available for the remaining 52 patients. Survival was compared with that of a cohort of 157 control patients recruited from the waiting list based on similar characteristics. Of these patients, 108 were lost to follow-up or underwent surgery or interventions performed by other missions, leaving 49 for comparison. The functioning of the repaired valves or valvular prosthesis was examined by echocardiography. Results The mean follow-up time among the 52 (65% women) surgical patients and 49 (76% women) controls was 4.1 years and 3.6 years, respectively. In the surgical group, 46 (88%), 25 (48%), and 18 (35%) patients underwent mitral, tricuspid, and aortic valve surgeries, respectively. The survival rate at last follow-up was 83% in the surgical group and 57% in the control group ( P = 0.004). At their last follow-up, four patients had moderate valvular obstruction and none had severe valvular dysfunction. Conclusions Cardiac surgery for severe chronic RHD is feasible in LMICs if the service is well-structured and can improve survival at mid-term follow-up. The durability of both repaired and replaced valves was good.
No takes yet. Share an insight, caveat, or question.
Hauge et al. (2026) conducted an observational in severe chronic rheumatic heart disease (n=101). open-heart surgery vs. historical control (medically treated patients) was evaluated on mortality rate (RR 1.51, 95% CI 1.15-1.97, p=0.004). Open-heart surgery for severe chronic rheumatic heart disease improved survival rates by 26% compared to controls, with 83% survival in the surgical group versus 57% in the control group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: